Sandoz expands partnership with World Child Cancer

Sandoz announces the expansion of a pilot project with leading charity World Child Cancer, aimed at improving access to treatment and optimizing survival outcomes for children suffering from cancer in four developing countries.

The agreement builds on an existing partnership with World Child Cancer in the Philippines, where Sandoz is funding staff training needs and helping children to access diagnosis and subsequent treatment. It expands the partnership to cover three additional countries across three continents: Ghana, Mexico and Myanmar.

These particular projects were chosen because of the gravity of the situation in the four regions concerned: across all four, an estimated 6000 children develop cancer each year, but only approximately 20 per cent even receive a diagnosis, let alone effective treatment.

The expanded partnership highlights Sandoz's commitment to work together with key stakeholders worldwide to expand access to healthcare. As a targeted philanthropy project, the work with World Child Cancer complements Sandoz’s broader Novartis Corporate Responsibility efforts across a number of lower income countries.